TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
TRANSGENE

BRIEF

published on 05/22/2025 at 17:50, 6 months 13 days ago

Transgene to Present Phase I Data on Cancer Vaccine TG4050 at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Phase I Data
BRIEF

published on 05/22/2025 at 17:50, 6 months 13 days ago

Transgene présentera les données de phase I sur le vaccin contre le cancer TG4050 à l'ASCO 2025

Vaccin Contre Le Cancer Transgene TG4050 ASCO 2025 Données De La Phase I
PRESS RELEASE

published on 05/22/2025 at 17:45, 6 months 13 days ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
BRIEF

published on 04/10/2025 at 20:20, 7 months 24 days ago

Transgene makes available the 2024 Universal Registration Document

AMF Social Responsibility Immunotherapy Registration Document Transgene
BRIEF

published on 04/10/2025 at 20:20, 7 months 24 days ago

Mise à disposition du Document d’Enregistrement Universel 2024 par Transgene

AMF Immunothérapie Responsabilité Sociale Document D'enregistrement Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 7 months 24 days ago

Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene announces availability of its 2024 Universal Registration Document (URD) containing financial reports and ESG factors. French & English versions can be accessed online

Financial Reports Transgene ESG Factors 2024 Universal Registration Document French Version
PRESS RELEASE

published on 04/10/2025 at 20:15, 7 months 24 days ago

Mise à disposition du Document d’Enregistrement Universel (DEU) 2024 de Transgene
Transgene annonce la mise à disposition de son Document d'Enregistrement Universel 2024 auprès de l'AMF, contenant des informations financières et RSE

AMF RSE Informations Financières Document D'Enregistrement Universel Transgene
BRIEF

published on 03/27/2025 at 17:50, 8 months 8 days ago

Transgene: major advances and outlook for 2025

Immunotherapy Head And Neck Cancer 2024 Financial Results TG4050 Vaccine Myvac® Platform
BRIEF

published on 03/27/2025 at 17:50, 8 months 8 days ago

Transgene : avancées majeures et perspectives 2025

Immunothérapie Cancer De La Tête Et Du Cou Résultats Financiers 2024 Vaccin TG4050 Plateforme Myvac®
PRESS RELEASE

published on 03/27/2025 at 17:45, 8 months 8 days ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof

Accesswire

Published on 12/05/2025 at 17:15, 13 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 28 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 28 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 3 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 18 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 10 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 10 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 29 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE